Opioid Induced Constipation (OIC) Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
According to 99Strategy, the Global Opioid Induced Constipation (OIC) Drugs Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Opioid Induced Constipation (OIC) Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
- Asia Pacific
- North America
- Europe
- South America
- Middle East & Africa
- Ironwood Pharmaceuticals Inc
- Daiichi Sankyo Co Ltd
- Pfizer
- Progenics Pharmaceuticals Inc
- Shionogi & Co., Ltd
- Allergan Plc
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma AG
- Mundipharma International Limited
- Ono Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma Inc
- Valeant Pharmaceuticals International
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Others
- Generic and Branded Prescribed Drugs
- Over The Counter Drugs
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Overview of the Opioid Induced Constipation (OIC) Drugs market including production, consumption, status & forecast and market growth
- 2015-2018 historical data and 2019-2025 market forecast
- Geographical analysis including major countries
- Overview the product type market including development
- Overview the end-user market including development
1 INDUSTRIAL CHAIN OVERVIEW
1.1 Opioid Induced Constipation (OIC) Drugs Industry
1.1.1 Overview
1.1.2 Characteristics of Opioid Induced Constipation (OIC) Drugs
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Drug Type
1.3.1 Lubiprostone
1.3.2 Methyl Naltrexone Bromide
1.3.3 Naldemedine
1.3.4 Alvimopan
1.3.5 Others
1.4 Product List By Prescription Type
1.4.1 Generic and Branded Prescribed Drugs
1.4.2 Over The Counter Drugs
1.5 End-Use List
1.5.1 Demand in Hospital Pharmacies
1.5.2 Demand in Retail Pharmacies
1.5.3 Demand in Online Pharmacies
1.6 Global Market Overview
1.6.1 Global Market Size and Forecast, 2015-2025
1.6.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.6.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.6.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 MAJOR MANUFACTURERS INTRODUCTION
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 Ironwood Pharmaceuticals Inc Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Daiichi Sankyo Co Ltd Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Pfizer Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Progenics Pharmaceuticals Inc Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Shionogi & Co., Ltd Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Allergan Plc Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Nektar Therapeutics Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Purdue Pharma Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 S.L.A. Pharma AG Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Mundipharma International Limited Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Ono Pharmaceutical Co., Ltd Overview
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Takeda Pharmaceutical Company Limited Overview
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Theravance Biopharma Inc Overview
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Valeant Pharmaceuticals International Overview
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Cosmo Pharmaceuticals SA Overview
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Daewoong Pharmaceutical Overview
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 C.B. Fleet Company Overview
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Sucampo Pharmaceuticals Overview
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
4 MARKET COMPETITION PATTERN
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 PRODUCT TYPE SEGMENT
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Drug Type
5.2.1 Market in Lubiprostone
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Methyl Naltrexone Bromide
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in Naldemedine
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Alvimopan
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in Others
5.2.5.1 Market Size
5.2.5.2 Situation & Development
5.3 Segment Subdivision by Prescription Type
5.3.1 Market in Generic and Branded Prescribed Drugs
5.3.1.1 Market Size
5.3.1.2 Situation & Development
5.3.2 Market in Over The Counter Drugs
5.3.2.1 Market Size
5.3.2.2 Situation & Development
6 END-USE SEGMENT
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospital Pharmacies
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Retail Pharmacies
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Online Pharmacies
6.2.3.1 Market Size
6.2.3.2 Situation & Development
7 MARKET FORECAST & TREND
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast by Drug Type
7.2.2 Product Type Forecast by Prescription Type
7.2.3 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 PRICE & CHANNEL
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 MARKET DRIVERS & INVESTMENT ENVIRONMENT
9.1 Market Drivers
9.2 Investment Environment
10 RESEARCH CONCLUSION
1.1 Opioid Induced Constipation (OIC) Drugs Industry
1.1.1 Overview
1.1.2 Characteristics of Opioid Induced Constipation (OIC) Drugs
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Drug Type
1.3.1 Lubiprostone
1.3.2 Methyl Naltrexone Bromide
1.3.3 Naldemedine
1.3.4 Alvimopan
1.3.5 Others
1.4 Product List By Prescription Type
1.4.1 Generic and Branded Prescribed Drugs
1.4.2 Over The Counter Drugs
1.5 End-Use List
1.5.1 Demand in Hospital Pharmacies
1.5.2 Demand in Retail Pharmacies
1.5.3 Demand in Online Pharmacies
1.6 Global Market Overview
1.6.1 Global Market Size and Forecast, 2015-2025
1.6.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.6.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.6.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 MAJOR MANUFACTURERS INTRODUCTION
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 Ironwood Pharmaceuticals Inc Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Daiichi Sankyo Co Ltd Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Pfizer Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Progenics Pharmaceuticals Inc Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Shionogi & Co., Ltd Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Allergan Plc Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Nektar Therapeutics Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Purdue Pharma Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 S.L.A. Pharma AG Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Mundipharma International Limited Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Ono Pharmaceutical Co., Ltd Overview
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Takeda Pharmaceutical Company Limited Overview
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Theravance Biopharma Inc Overview
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Valeant Pharmaceuticals International Overview
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Cosmo Pharmaceuticals SA Overview
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Daewoong Pharmaceutical Overview
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 C.B. Fleet Company Overview
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Sucampo Pharmaceuticals Overview
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
4 MARKET COMPETITION PATTERN
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 PRODUCT TYPE SEGMENT
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Drug Type
5.2.1 Market in Lubiprostone
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Methyl Naltrexone Bromide
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in Naldemedine
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Alvimopan
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in Others
5.2.5.1 Market Size
5.2.5.2 Situation & Development
5.3 Segment Subdivision by Prescription Type
5.3.1 Market in Generic and Branded Prescribed Drugs
5.3.1.1 Market Size
5.3.1.2 Situation & Development
5.3.2 Market in Over The Counter Drugs
5.3.2.1 Market Size
5.3.2.2 Situation & Development
6 END-USE SEGMENT
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospital Pharmacies
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Retail Pharmacies
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Online Pharmacies
6.2.3.1 Market Size
6.2.3.2 Situation & Development
7 MARKET FORECAST & TREND
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast by Drug Type
7.2.2 Product Type Forecast by Prescription Type
7.2.3 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 PRICE & CHANNEL
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 MARKET DRIVERS & INVESTMENT ENVIRONMENT
9.1 Market Drivers
9.2 Investment Environment
10 RESEARCH CONCLUSION
LIST OF TABLES
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Drug Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Prescription Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Ironwood Pharmaceuticals Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Ironwood Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Daiichi Sankyo Co Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Daiichi Sankyo Co Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Progenics Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Shionogi & Co., Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Shionogi & Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Allergan Plc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Allergan Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Nektar Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Purdue Pharma Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Purdue Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table S.L.A. Pharma AG Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of S.L.A. Pharma AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Mundipharma International Limited Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Mundipharma International Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Ono Pharmaceutical Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Takeda Pharmaceutical Company Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Theravance Biopharma Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Theravance Biopharma Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Valeant Pharmaceuticals International (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals SA Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Cosmo Pharmaceuticals SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Daewoong Pharmaceutical Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Daewoong Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table C.B. Fleet Company Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of C.B. Fleet Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sucampo Pharmaceuticals Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Drug Type Segment 2019-2025, in Million USD
Table Global Market Volume by Drug Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Drug Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Prescription Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Ironwood Pharmaceuticals Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Ironwood Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Daiichi Sankyo Co Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Daiichi Sankyo Co Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Progenics Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Shionogi & Co., Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Shionogi & Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Allergan Plc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Allergan Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Nektar Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Purdue Pharma Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Purdue Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table S.L.A. Pharma AG Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of S.L.A. Pharma AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Mundipharma International Limited Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Mundipharma International Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Ono Pharmaceutical Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Takeda Pharmaceutical Company Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Theravance Biopharma Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Theravance Biopharma Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Valeant Pharmaceuticals International (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals SA Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Cosmo Pharmaceuticals SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Daewoong Pharmaceutical Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Daewoong Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table C.B. Fleet Company Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of C.B. Fleet Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sucampo Pharmaceuticals Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Drug Type Segment 2019-2025, in Million USD
Table Global Market Volume by Drug Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
LIST OF FIGURES
Figure Opioid Induced Constipation (OIC) Drugs Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Lubiprostone, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Lubiprostone, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Naldemedine, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Naldemedine, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Alvimopan, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Alvimopan, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Generic and Branded Prescribed Drugs, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Generic and Branded Prescribed Drugs, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Over The Counter Drugs, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Over The Counter Drugs, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Retail Pharmacies, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Retail Pharmacies, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Online Pharmacies, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Online Pharmacies, 2015-2018, in Volume
Figure Opioid Induced Constipation (OIC) Drugs Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Lubiprostone, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Lubiprostone, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Naldemedine, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Naldemedine, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Alvimopan, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Alvimopan, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Generic and Branded Prescribed Drugs, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Generic and Branded Prescribed Drugs, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Over The Counter Drugs, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Over The Counter Drugs, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Retail Pharmacies, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Retail Pharmacies, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Online Pharmacies, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Online Pharmacies, 2015-2018, in Volume
